Free Trial

Rani Therapeutics (RANI) Institutional Ownership

Rani Therapeutics logo
$1.40 +0.10 (+7.69%)
(As of 12/20/2024 05:40 PM ET)

Institutional Ownership Changes (13F Filings) for Rani Therapeutics (NASDAQ:RANI)

Current
Institutional Ownership
Percentage
30.19%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$525.89K
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$940.82K
Get RANI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rani Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

RANI Institutional Buying and Selling by Quarter

Rani Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024 Geode Capital Management LLC172,261$372K0.0%+14.3%0.323%
11/15/2024 United Services Automobile Association302,743$654K0.0%-3.0%0.567%
11/15/2024 Stifel Financial Corp269,768$583K0.0%+100.4%0.505%
11/8/2024 King Luther Capital Management Corp81,129$175K0.0%+44.5%0.152%
8/14/2024 Marshall Wace LLP21,247$81K0.0%N/A0.042%
8/9/2024 Renaissance Technologies LLC21,700$82K0.0%-69.1%0.043%
8/7/2024 United Services Automobile Association312,095$1.19M0.0%-35.2%0.619%
5/10/2024 Vanguard Group Inc.685,303$2.13M0.0%+2.5%1.366%
2/14/2024 Alpha Square Group S LLC58,946$196K0.2%-32.2%0.118%
8/10/2023 King Luther Capital Management Corp56,129$231K0.0%N/A0.113%
8/4/2023 Choreo LLC19,813$82K0.0%-20.2%0.040%
5/11/2023Icon Wealth Partners LLC12,757$66K0.0%N/A0.026%
5/11/2023 Alphabet Inc.448,492$2.31M0.1%-12.1%0.908%
2/8/2023 Prime Capital Investment Advisors LLC33,502$198K0.0%N/A0.068%
11/18/2022TPB Wealth Advisors48,129$461K0.2%-33.0%0.098%
11/16/2022 Alphabet Inc.714,471$6.85M0.3%N/A1.453%
11/3/2022 Motco48,129$461K0.0%N/A0.098%
10/28/2022 Lafayette Investments Inc.19,893$191K0.1%N/A0.040%
10/17/2022 Canton Hathaway LLC16,200$155K0.1%+88.4%0.033%
10/14/2022 Iowa State Bank18,862$181K0.1%N/A0.038%
8/8/2022 Islay Capital Management LLC9,611$99K0.1%N/A0.020%
8/8/2022Crossvault Capital Management LLC14,285$148K0.1%N/A0.029%
7/29/2022Aspireon Wealth Advisors71,811$742K0.3%N/A0.146%
7/20/2022 Canton Hathaway LLC8,600$89K0.0%N/A0.017%
6/15/2022 Lasry Marc62,828$848K0.4%N/A0.128%
5/17/2022 Lasry Marc62,828$848K0.4%N/A0.128%
5/13/2022 United Services Automobile Association481,300$6.50M0.1%N/A0.979%
2/3/2022 Advisor Group Holdings Inc.21,072$344K0.0%N/A0.043%
1/6/2022 Canton Hathaway LLC5,000$82K0.0%-50.0%0.010%
11/16/2021 Squarepoint Ops LLC50,000$891K0.0%N/A0.102%
11/15/2021 Caas Capital Management LP75,000$1.34M0.0%N/A0.153%
11/10/2021 Goldman Sachs Group Inc.60,649$1.08M0.0%N/A0.124%
(Data available from 1/1/2016 forward)

RANI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RANI shares?

During the previous two years, 12 institutional investors and hedge funds held shares of Rani Therapeutics. The most heavily invested institutionals were Alphabet Inc. ($2.31M), Vanguard Group Inc. ($2.13M), United Services Automobile Association ($654K), Stifel Financial Corp ($583K), Geode Capital Management LLC ($372K), Prime Capital Investment Advisors LLC ($198K), and Alpha Square Group S LLC ($196K).Learn more on RANI's institutional investors.

What percentage of Rani Therapeutics stock is owned by institutional investors?

30.19% of Rani Therapeutics stock is owned by institutional investors. Learn more on RANI's institutional investor holdings.

Which institutional investors have been buying Rani Therapeutics stock?

The following institutional investors have purchased Rani Therapeutics stock in the last 24 months: Stifel Financial Corp ($135.15K), King Luther Capital Management Corp ($81.13K), Prime Capital Investment Advisors LLC ($33.50K), Geode Capital Management LLC ($21.53K), Marshall Wace LLP ($21.25K), Vanguard Group Inc. ($16.96K), and Icon Wealth Partners LLC ($12.76K).

How much institutional buying is happening at Rani Therapeutics?

Institutional investors have bought a total of 322,266 shares in the last 24 months. This purchase volume represents approximately $1.02M in transactions.

Which Rani Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Rani Therapeutics stock in the last 24 months: United Services Automobile Association ($178.56K), Alphabet Inc. ($61.64K), Renaissance Technologies LLC ($48.60K), Alpha Square Group S LLC ($28K), and Choreo LLC ($5K).

How much institutional selling is happening at Rani Therapeutics?

Institutional investors have sold a total of 321,793 shares in the last 24 months. This volume of shares sold represents approximately $1.28M in transactions.



This page (NASDAQ:RANI) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners